The appeal of a proposed reduction for multiple myeloma is dismissed as the October 2024 rating decision was merely a non-final proposal and not an adjudicative determination with which the Veteran disagreed.
The deciding factor: The October 2024 rating decision did not constitute an adjudicative determination, but rather a proposal for future adjudication, and the AOJ subsequently continued his 100 percent rating in a March 2025 rating decision.
- Claimed conditions
- multiple myeloma
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- April 7, 2025
- Citation
- A25031572
What this means for you
A dismissal means the Board did not decide the issue on its merits — usually because it was withdrawn or had become moot. It says more about procedure than about whether a claim like this can win.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied service connection for multiple myeloma, finding no evidence that the Veteran's condition was related to his military service.
- Dismissed
The veteran withdrew all claims on appeal, and the Board dismissed the appeal.
- Granted
The Board granted service connection for multiple myeloma, finding that the Veteran's condition was caused by his conceded in-service toxic risk exposure activities.
- Remanded (sent back)
The Board remands the Veteran's claim for service connection for multiple myeloma due to a pre-decisional duty to assist error in not providing the Veteran with a VA examination and medical opinion.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.